RT/HT Combo Halves Prostate Ca Mortality
RT/HT Combo Halves Prostate Ca Mortality
N Osterweil
20080826
2008 Sept 26
Elsevier Global Medical News
Find more items about these cancer types:
RT/HT Combo Halves Prostate Ca Mortality
(00:01:57) Elsevier Global Medical News, 2008 Sept 26, N Osterweil
Dr. Anders Widmark is Professor of Radiation Oncology, Umea University, Umea, Sweden.
A phase III randomized trial of ~900 men with localized prostate cancer found that adding radiotherapy to neoadjuvant hormonal therapy (total androgen blockade followed by continuous antiandrogen therapy) cut prostate cancer-specific mortality from 18% to 8.5% and resulted in only a slight increase in adverse effects.
/Images/Dr_Anders_Widmark_Video_tcm8-165865.jpg
See related videos to:
ASTRO 2008
Related Link:
Copyright © 2010 International Medical News Group
Subscribe Now »
Subscribe Now »
Most Viewed Video
Expert Gives Overview of Gamechangers at 2011 ASCO Annual Meeting
Elsevier Global Medical News, 2011 Jun 4
